Processa Pharmaceuticals, Inc

/Processa Pharmaceuticals, Inc

Follow-on

Processa Pharmaceuticals, Inc

Biopharmaceutical

FOLLOW-ON UPLISTING: Processa Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the development of drug products that are intended to provide treatment for and improve the survival and/or quality of life of patients who have a high unmet medical need condition or who have no alternative treatment.

Symbol

PCSA

Last Closing Price
$9.79

Shares
2,150,000

Anticipated Date
October 2, 2020

Underwriters
THE BENCHMARK COMPANY, LLC,CRAIG-HALLUM CAPITAL GROUP LLC

This offering is no longer available

To view the prospectus for Processa Pharmaceuticals, Inc, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277